lysis patient leukemic cells cells Fab antibody cross-linked Fab antibody Fab Fab bispecific hybrid antibody Ab bispecific Ab molecular mass Kd capacity cells lymphoblastic leukemia ALL cells cytotoxic CTLs patient ALL cells addition bispecific Ab effector CTLs peripheral blood mononuclear cells PBMCs CTL clones PBMCs cytotoxicity ALL cells activity addition bispecific Ab CTL clones lacked cytotoxicity ALL cells addition bispecific Ab significant level cytotoxicity CTLs ALL patients significant cytotoxicity autologous ALL cells addition bispecific Ab Ab cytotoxicity CTLs leukemic cells targets findings bispecific Ab immunotherapy patients ALL 